Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/77705
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAndrew, N.-
dc.contributor.authorKearney, D.-
dc.contributor.authorSelva-Nayagam, D.-
dc.date.issued2012-
dc.identifier.citationActa Ophthalmologica, 2012; online(8):1-7-
dc.identifier.issn1755-375X-
dc.identifier.issn1755-3768-
dc.identifier.urihttp://hdl.handle.net/2440/77705-
dc.description.abstractIgG4-related orbital disease (IgG4-ROD) is a recently described condition that may account for a significant proportion of idiopathic lymphoplasmacytic or sclerotic orbital lesions. This study is the first meta-analysis of published cases and reveals several differences between IgG4-related disease affecting the orbit and that affecting the pancreas. IgG4-ROD affects a slightly younger group of patients, affects men and women approximately equally, is commonly associated with salivary gland lesions, is associated with a relatively higher serum IgG4 and may confer an increased risk of non-Hodgkin Lymphoma. Its pathogenesis may involve an immune response to antigen exposure in the upper aerodigestive tract.-
dc.description.statementofresponsibilityNicholas Andrew, Daniel Kearney and Dinesh Selva-
dc.language.isoen-
dc.publisherWiley-Blackwell Munksgaard-
dc.rights© 2012 The Authors.-
dc.source.urihttp://dx.doi.org/10.1111/j.1755-3768.2012.02526.x-
dc.subjectdacryoadenitis-
dc.subjectIgG4-
dc.subjectIgG4-related disease-
dc.subjectIgG4-related orbital disease-
dc.subjectorbital-
dc.subjectreview-
dc.titleIgG4-related orbital disease: a meta-analysis and review-
dc.typeJournal article-
dc.identifier.doi10.1111/j.1755-3768.2012.02526.x-
pubs.publication-statusPublished-
dc.identifier.orcidSelva-Nayagam, D. [0000-0002-2169-5417]-
Appears in Collections:Aurora harvest 4
Opthalmology & Visual Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.